OrganiGram Holdings Inc
TSX:OGI
OrganiGram Holdings Inc
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.
Revenue Growth: Net revenue rose to $65.3 million, up 49% year-over-year, driven by Canadian operations, the Motif integration, and higher international sales.
Profitability: Adjusted EBITDA reached $5.3 million, a 273% increase over last year, and the company posted a net income of $20 million versus a net loss last year.
Margins: Adjusted gross margin was stable sequentially at 38%, up 500 basis points year-over-year.
Market Leadership: Organigram maintained its #1 position in the Canadian market with 11.3% share in Q1, despite a temporary 500 bps market share drop due to a BC labor strike.
International: International sales grew 55% year-over-year to $5 million, though sequentially lower due to out-of-spec product; management expects recovery and further growth.
Operational Improvements: Advances in plant science increased yields, potency, and cost efficiency, supporting margin expansion.
Guidance: Management reaffirmed full-year guidance for revenue exceeding $300 million and positive free cash flow.
